gz
Newbie
Posts: 10 
|
Post by gz on Jan 18, 2016 20:26:49 GMT -5
Hey everyone so I would like to see what kind of ideas everyone has to help our company get the word out about Afrezza. I'm hoping we can get a bunch of good ideas sent to Matt, and hopefully he finds some good ideas to use. As shareholders, we own this company and we all want it to succeed. We know cash is a problem, so maybe we can get some creative ideas that don't cost a lot.
I would like for MannKind to reach out to popular news/science pages on Facebook and have them do a short video or article on Afrezza. For example, I "f'ing" love science has over 23 million likes and a lot of their news gets shared thousands of times and liked tens of thousands of times. Another one would be AJ+, which posts about news and tech etc etc.
Just think if we were to get a few thousand shares, and people were to tell their friends/family about Afrezza. It would probably work a lot better than how SNY "tried" to get the word out.
I would love to hear some other ideas from all of us and maybe we can get a good enough list to Matt.
|
|
|
|
Post by prosper on Jan 18, 2016 22:05:54 GMT -5
Preaching to the choir is great.
I am sure dozens of ideas, some great, some delusional will hopefully be presented.
Matt as CEO is not going to have the time to read all our message board posts, and even if he appoints an assistant the question is how much editing will be required.
I dont know the answer to my statement, and I dont like the idea of PC editing, but perhaps we, as a group, could nominate and editor to be responsible for forwarding only the reasonable ideas to Matt directly?
|
|
|
|
Post by mnkdnewb on Jan 18, 2016 22:37:48 GMT -5
I vote cfield23 be the direct contact to Matt
|
|
|
|
Post by LosingMyBullishness on Jan 18, 2016 23:30:30 GMT -5
A dedicated afrezza YouTube channel that showcases real users and their specific afrezza usage, challenges and benefis. This is to get a ' that's-me' experience and some good advice along the first weeks of usage. Very cheap. Needs a good presenter to help the diabetics who showcases their situation to feel comfortable.
Second you need a celebrity that is a diabetic and works for broad audience. Most people see this with guy like Tom Hanks. If this person understands Afrezza and MNKD's situation as underdog this could be less expensive.
|
|
|
|
Post by robsacher on Jan 18, 2016 23:33:44 GMT -5
Hey everyone so I would like to see what kind of ideas everyone has to help our company get the word out about Afrezza. I'm hoping we can get a bunch of good ideas sent to Matt, and hopefully he finds some good ideas to use. As shareholders, we own this company and we all want it to succeed. We know cash is a problem, so maybe we can get some creative ideas that don't cost a lot. I would like for MannKind to reach out to popular news/science pages on Facebook and have them do a short video or article on Afrezza. For example, I "f'ing" love science has over 23 million likes and a lot of their news gets shared thousands of times and liked tens of thousands of times. Another one would be AJ+, which posts about news and tech etc etc. Just think if we were to get a few thousand shares, and people were to tell their friends/family about Afrezza. It would probably work a lot better than how SNY "tried" to get the word out. I would love to hear some other ideas from all of us and maybe we can get a good enough list to Matt. This is a brilliant idea. I hope Matt will read it. |
|
|
|
Post by coo2002coo on Jan 19, 2016 2:19:54 GMT -5
Re-establish the contact with those 6000 patients in clinical trials during the past 10 years. Help them to get insurance coverage and invite them (those qualified per label) to participate in Real Time Diabetic Management program, if any and share results with Afrezza Advocate Council. Get the momentum back before new pricing policy is introduced for further reinforcement of building up market share.
|
|
|
|
Post by slugworth008 on Jan 19, 2016 7:15:43 GMT -5
Hey everyone so I would like to see what kind of ideas everyone has to help our company get the word out about Afrezza. I'm hoping we can get a bunch of good ideas sent to Matt, and hopefully he finds some good ideas to use. As shareholders, we own this company and we all want it to succeed. We know cash is a problem, so maybe we can get some creative ideas that don't cost a lot. I would like for MannKind to reach out to popular news/science pages on Facebook and have them do a short video or article on Afrezza. For example, I "f'ing" love science has over 23 million likes and a lot of their news gets shared thousands of times and liked tens of thousands of times. Another one would be AJ+, which posts about news and tech etc etc. Just think if we were to get a few thousand shares, and people were to tell their friends/family about Afrezza. It would probably work a lot better than how SNY "tried" to get the word out. I would love to hear some other ideas from all of us and maybe we can get a good enough list to Matt. Love it! Email this idea to Matt! |
|
|
|
Post by fofos2000i on Jan 19, 2016 7:32:01 GMT -5
|
|
|
|
Post by mindovermatter on Jan 19, 2016 8:01:40 GMT -5
Re-establish the contact with those 6000 patients in clinical trials during the past 10 years. Help them to get insurance coverage and invite them (those qualified per label) to participate in Real Time Diabetic Management program, if any and share results with Afrezza Advocate Council. Get the momentum back before new pricing policy is introduced for further reinforcement of building up market share. Many of those in the clinical trials were not in the United States. |
|
|
|
Post by coo2002coo on Jan 19, 2016 9:24:36 GMT -5
Yeah. So maybe we can start with those in the US & see if we can replicate the model in other countries later on.
|
|
|
|
Post by cgiscgis on Jan 19, 2016 11:14:42 GMT -5
MannKind needs a new modern looking website 2.0 style with all the social media channels plus videos.
|
|
|
|
Post by agedhippie on Jan 19, 2016 11:19:41 GMT -5
Yeah. So maybe we can start with those in the US & see if we can replicate the model in other countries later on. Can you do that? I think it's a HIPAA violation, and probably an ethics violation as well. Just because you are on a trial it doesn't give anyone the right to market to you. It would definitely be a breach of the EU privacy directive (data may only be used for the purpose for which it was given, and marketing was not the reason) in the EU and some of the trial patients were in Germany I think. |
|
|
|
Post by dreamboatcruise on Jan 19, 2016 11:19:42 GMT -5
A dedicated afrezza YouTube channel that showcases real users and their specific afrezza usage, challenges and benefis. This is to get a ' that's-me' experience and some good advice along the first weeks of usage. Very cheap. Needs a good presenter to help the diabetics who showcases their situation to feel comfortable. Second you need a celebrity that is a diabetic and works for broad audience. Most people see this with guy like Tom Hanks. If this person understands Afrezza and MNKD's situation as underdog this could be less expensive. One problem with freewheeling out of the box thinking is that a lot of it may well be out of the box allowed by the FDA. For instance, while an individual user can't be prohibited from posting something about their use of Afrezza (if they aren't making money from it), MNKD is constrained in what they can do to market Afrezza. You'll notice a stark contrast in TV ads from supplement companies not regulated by FDA and those from drug companies. Rules/laws allow a supplement company to show the 4 people that lost tons of weight with a barely noticeable disclaimer at the bottom that admits it isn't scientific and may not be typical. A drug company cannot use anecdotal information in marketing... that is why you don't see that in drug ads and there is almost always language like "xyz MAY help blah, blah, blah". You never see someone say "it was the greatest, my blah, blah cleared up in a week". If the clinical trials really have the statistical proof, a company might be able to go so far as to say "xyz helps reduce blah, blah within a week for most patients"... but there has to be the clinical trials, not anecdotal. You could pay for a celebrity (and we don't have the money for Tom Hanks), but they still couldn't endorse the product using their anecdotal experience with it. Youtub doesn't change the rules about what MNKD can do in marketing material. |
|
|
|
Post by spinaltiger on Jan 19, 2016 11:25:37 GMT -5
Robert Sacher, Will you be writing an updated article based on everything that has happened and what your perspective is on the stock for other longs or new investors? Although I did like your articles on seeking, I assess my expectations for the company have soured considerably. I would recommend writing an article, especially since the hit pieces are out and they are bringing up some cogent points given available information.
|
|
|
|
Post by dreamboatcruise on Jan 19, 2016 11:27:13 GMT -5
Yeah. So maybe we can start with those in the US & see if we can replicate the model in other countries later on. Can you do that? I think it's a HIPAA violation, and probably an ethics violation as well. Just because you are on a trial it doesn't give anyone the right to market to you. It would definitely be a breach of the EU privacy directive (data may only be used for the purpose for which it was given, and marketing was not the reason) in the EU and some of the trial patients were in Germany I think. Though it would seem logical that a company doing a trial that they felt was successful might solicit the trial participants to volunteer contact info for when the drug is commercially available. It would seem strange if there were a prohibition on doing that. I personally would not find it a violation of my privacy if a company contacted me after the fact if it were about the particular drug for which I had done a study... but perhaps you are right that it could be interpreted as misuse of data. |
|
